Executive Bios

Noven Officers

	JEFFREY F. EISENBERG Jeffrey Eisenberg serves as Noven’s President & Chief Executive Officer and as President of Novogyne Pharmaceuticals, Noven's joint venture with Novartis Pharmaceuticals Corporation. He has been part of Noven’s senior management team since 1998, having previously served as Senior Vice President – Strategic Alliances, and as General Counsel. From 1995 through 1998, he served as Associate General Counsel and then as Acting General Counsel of IVAX Corporation. Prior to IVAX, he was a lawyer in the corporate securities department of the law firm of Steel Hector & Davis.
	PETER G. AMANATIDES Peter Amanatides joined Noven in September 2008 and serves as Vice President – Quality Assurance & Quality Control. He has over 20 years of diverse pharmaceutical and biotechnology industry experience. Prior to joining Noven, he served in several senior quality roles at DSM Pharmaceuticals, Inc., most recently as Senior Director – Quality Operations & Regulatory Affairs, the senior-most quality officer at DSM Pharmaceuticals. Prior to his career at DSM, he was Director of Quality Systems at Celera Genomics. Mr. Amanatides holds a Master of Science degree in biotechnology and molecular biology from Hood College and a Bachelor of Science Degree in biology from Regents College.
	STEVEN M. DINH Steven Dinh joined Noven in June 2008 and serves as Vice President and Chief Scientific Officer. He has more than 25 years' experience in drug delivery, biotechnology, pharmaceutical development and polymer engineering. Prior to joining Noven, he served as Vice President of Research and Technology Development and Co-Chair – Office of the President for Emisphere Technologies. Earlier, he served as Chief Scientific Officer and Vice President of Research & Development for Lavipharm Laboratories, and before that, he held several senior-level R&D positions at Novartis Pharmaceuticals Corporation and Ciba-Geigy. Mr. Dinh has co-authored three books, over 30 articles for scientific publications, and more than 100 abstracts. He holds a Doctor of Science degree from the Massachusetts Institute of Technology, a Masters of Science degree from Cornell University, and a Bachelor of Engineering degree from Cooper Union.
	PATRICK GALLAGHER Patrick Gallagher joined Noven in February 2010 and serves as Vice President – Business Development. He has over 25 years’ experience in the pharmaceutical, biotechnology and drug delivery industries. Prior to joining Noven, he served as Senior Vice President, Business Development, Marketing & Sales at Acusphere. Previously, he served as Vice President, Corporate Business Development at Mylan Laboratories. Earlier, he held senior director positions at Bristol-Myers Squibb and Johnson & Johnson. As a corporate development and strategic planning consultant, he has also helped pharmaceutical, biotech and medical device industry clients develop and successfully execute critical business initiatives.
	RICHARD P. GILBERT Richard Gilbert joined Noven in December 2004 and serves as Vice President – Operations. He has over 22 years of experience in operations and manufacturing. Prior to joining Noven, he served as Vice President, Manufacturing Operations, at ConvaTec (a Bristol-Myers Squibb Company). Prior to ConvaTec, he held various senior roles at London International Group, LLC, The Tensar Corporation, and Richmond Technology.
	JOSEPH C. JONES Joseph Jones has been with Noven since January 2001 and serves as Vice President – Corporate Affairs, with principal responsibility for corporate planning, corporate communications, and the integration of Noven with its parent company, Hisamitsu Pharmaceutical. Prior to joining Noven, he was President of SHD Strategic, L.C., a corporate communications consulting firm, and before that he served as Vice President, Investor Relations and Government Affairs for IVAX Corporation. Prior to joining IVAX, he was a partner in the corporate securities department of the law firm of Steel Hector & Davis.
	FRANK KYLER Frank Kyler joined Noven in July 2010 and serves as Vice President – Human Resources. Prior to Noven, he served as Vice President, Human Resources for HEICO Corporation (NYSE: HEI), where he was responsible for Global Talent development strategies and systems. He earned his Master of Business Administration degree in Human Resources from the State University of New York (Buffalo) and his Bachelor of Business Administration degree in Finance from Canisius College.
	JOEL S. LIPPMAN, M.D. Joel Lippman joined Noven in July 2008 and serves as Executive Vice President – Product Development & Chief Medical Officer. Dr. Lippman is an obstetrician-gynecologist certified by the American Board of Obstetrics and Gynecology with nearly 20 years of clinical development and medical affairs experience in the pharmaceutical and device industries. Prior to joining Noven, Dr. Lippman served as Worldwide Vice President – Medical Affairs & Chief Medical Officer and as a member of the Global Management Board at Ethicon, Inc., a Johnson & Johnson company. Earlier, he served as Vice President – Clinical Trials at Ortho-McNeil Pharmaceutical, Inc., also a Johnson & Johnson company, and before that, he served in a number of clinical development, medical affairs and related roles at Wyeth-Ayerst Laboratories. Dr. Lippman holds a Medical Degree from New York Medical College and a Masters in Public Health from Harvard University School of Public Health, and is a Fellow of the American College of Obstetricians and Gynecologists.
	JEFF T. MIHM Jeff Mihm has been with Noven since 2003 and serves as Vice President, Chief Administrative Officer & General Counsel. Prior to Noven, he served as Senior Corporate Counsel to Panamerican Beverages, Inc., the world's third largest Coca-Cola bottler at the time, and previously was a partner in the corporate securities department of the law firm of Steel Hector & Davis.
	ANDREW C. PANAGY Andrew C. Panagy joined Noven in January 2010 and serves as Vice President – Marketing & Sales. He has over 30 years experience in pharmaceutical and biotechnology marketing and sales, strategic planning and business management. Prior to joining Noven, he served as Vice President and Global Business Manager of Wyeth Pharmaceuticals’ Women’s Health Care business unit, with principal responsibility for that unit’s menopausal product portfolio, and as Wyeth’s Vice President, U.S. Marketing – Women’s Health Care. Previously, he served as Vice President, U.S. Women’s Health Care Marketing at Pfizer/Parke-Davis. Earlier, he held senior level positions at Neuromedical Systems, MEDED Healthcare Group, and the Ayerst Labs Division of American Home Products.
	MICHAEL D. PRICE Michael Price joined Noven in November 2007 and serves as Vice President and Chief Financial Officer. He is a CPA with over 25 years of experience as a financial executive. From 1992 to 2006, he served as Vice President, Chief Financial Officer, Treasurer and Secretary for Bentley Pharmaceuticals, Inc., a NYSE listed specialty pharmaceuticals company. He also acted as a member of that company’s board of directors for nine years. Earlier in his career, he served as a senior executive with Carr Financial Group, and as Vice President - Finance with Premiere Group, Inc.